| Company: | Stryker Corporation |
|---|---|
| CEO: |
|
| Founded: | 1941 |
| Symbol: | SYK |
| Exchange: | NYSE |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| About |
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offeringslude devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, whichlude cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan. |
17 among 2804 companies
1941 Stryker Way
Portage | MI |
US
| Stryker Corporation;SYK;https://bullfincher.io/logos/us/SYK.png;stryker-corporation | 25116000000.00 |
|---|---|
| Abbott Laboratories;ABT;https://bullfincher.io/logos/us/ABT.png;abbott-laboratories | 44328000000.00 |
| Boston Scientific Corporation;BSX;https://bullfincher.io/logos/us/BSX.png;boston-scientific-corporation | 20074000000.00 |
| DexCom;DXCM;https://bullfincher.io/logos/us/DXCM.png;dexcom | 4662000000.00 |
Stryker Corporation was founded on 1941, which makes the company 85 years old.
Kevin A. Lobo is the CEO of Stryker Corporation.
Stryker Corporation operates in the Medical - Devices industry and the Healthcare sector.
Stryker Corporation has 56,000 employees.
In fiscal year 2025, Stryker Corporation generated a revenue of $25.12 Billion.
In fiscal year 2025, Stryker Corporation reported a net income of $3.25 Billion.
MedSurg is Stryker Corporation's biggest product segment, representing 62.3% of its total revenue.
Stryker Corporation went public on Mar 17, 1980, through its Initial Public Offering (IPO), and it has been 46 years since then.
Stryker Corporation's ticker symbol is SYK, and the company is listed on the NYSE stock market exchange.
Stryker Corporation's current stock price is $310.64 as of Jun 17, 2026.
Ranked #17among 2,804 companies based on market cap.
Competitors of Stryker Corporation include Abbott Laboratories, Boston Scientific Corporation and DexCom, and more.